FindTrial
Sign In

Effects of eye drop cyclosporine 0.05% on patients having dry eye disease

An Observational Study To Assess The Clinical Changes Of Topical Cyclosporine 0.05 percent Ophthalmic Solution In The Management Of Mild To Moderate Dry Eye Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072868
Enrollment
50
Registered
2024-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H55-H57- Other disorders of eye and adnexa

Interventions

Intervention1: Eye drop cyclosporine 0.05%: Dose-1 drop Frequency -two times in a day in affected eye Route -topical Duration- 6 months Cyclosporine is class of immunomodulators drugs .in eye it w

Sponsors

SMS medical college Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients who will give written informed consent. Patients with history of dry eye disease for a period of at least 6 months. patients with corrected Snellen VA of 20/200.

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity or intolerability to study medication or its component. patient with presence of punctal plugs or past history of permanent punctal occlusion. patient with lagophthalmos or clinically significant eyelid margin irregularity of either eye whether congenital or acquired.

Design outcomes

Primary

MeasureTime frame
Improvement in Dry eye sign and symptomsTimepoint: 4 months—

Secondary

MeasureTime frame
Improvement in BCVATimepoint: 4 months—

Countries

India

Contacts

Public ContactRaman

Swai man singh medical college Jaipur

drdschoudhary@gmail.com9252032662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026